SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-22-013424
Filing Date
2022-05-16
Accepted
2022-05-13 21:22:01
Documents
51
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 859451
2 ex31-1.htm EX-31.1 17905
3 ex31-2.htm EX-31.2 18134
4 ex32-1.htm EX-32.1 7564
5 ex32-2.htm EX-32.2 7260
  Complete submission text file 0001493152-22-013424.txt   3876093

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE hils-20220331.xsd EX-101.SCH 29335
7 XBRL CALCULATION FILE hils-20220331_cal.xml EX-101.CAL 33914
8 XBRL DEFINITION FILE hils-20220331_def.xml EX-101.DEF 117199
9 XBRL LABEL FILE hils-20220331_lab.xml EX-101.LAB 272170
10 XBRL PRESENTATION FILE hils-20220331_pre.xml EX-101.PRE 206189
45 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 480029
Mailing Address 245 MAIN STREET SUITE 204 CHESTER NJ 07930
Business Address 1200 ROUTE 22 EAST BRIDGEWATER NJ 08807 302-743-2995
Hillstream BioPharma Inc. (Filer) CIK: 0001861657 (see all company filings)

IRS No.: 842642541 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41210 | Film No.: 22925036
SIC: 2834 Pharmaceutical Preparations